Amylyx Pharmaceuticals used LinkedIn for investor communication and its management participated in conferences held in New York City and Boston on August 26, 2025.
2 reports, 1 independent
Updated Aug 26
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Amylyx Pharmaceuticals used LinkedIn for investor communication and its management participated in conferences held in New York City and Boston on August 26, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amylyx Pharmaceuticals
American biopharmaceutical company
Nothing else this week.
-
LinkedIn
American social networking website for people in professional occupations
-
New York City
most populous city in the United States
-
Boston
capital and largest city of Massachusetts, United States
Related events
- Investor conferences are scheduled in Boston, and the company advises investors to follow updates via LinkedIn.
- Edgewise Therapeutics announced news from Boulder, Colorado, and utilizes LinkedIn for its public communication.
- Nasdaq directs interested parties to LinkedIn for company information.
- LinkedIn was mentioned in connection with New York City as a place to follow for updates.
- BXP manages premier workplaces across the US, concentrating properties in Boston, Los Angeles, Seattle, and San Francisco, and uses LinkedIn for investor communication.
Coverage
Newest first; wire copies grouped- Business WireAmylyx Pharmaceuticals to Participate in Upcoming Investor Conferences CAMBRIDGE, Mass., August 26, 2025--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") toda
- Business WireAmylyx Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025 CAMBRIDGE, Mass., July 31, 2025--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the